Colorectal Cancer - Pipeline Review, 2015 is a new market research publication announced by Reportstack. This report provides an overview of Colorectal Cancer diagnostic tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer diagnostic tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
To view the table of contents and know more details, please visit Colorectal Cancer - Pipeline Review, 2015.
- Extensive coverage of the Colorectal Cancer diagnostic tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer diagnostic tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer diagnostic tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
A2K Technologies Abbott Diagnostics Advanced Marker Discovery, S.L. Advpharma Inc. Ambergen, Inc. Ambrilia Biopharma Inc. Applied Proteomics, Inc. Arizona State University ArtemixRx Asuragen, Inc. Bio Mark Ltd Biocartis SA Biodesix Inc. BioMarCare Technologies Ltd. BioMark Diagnostics Inc. BioMark Technologies Inc. BioMarker Strategies, LLC bioMerieux S.A. Biosceptre (Aust) Pty Ltd BioSystems International Biotechnostics GmbH Biotron Limited Castle Biosciences Incorporated Cellmid Limited Ceres Nanosciences, Inc. Cernostics Inc. ChemImage Corporation China Sky One Medical, Inc. Chinese University of Hong Kong Chronix Biomedical, Inc. Cleveland Diagnostics Inc. ColoPrev Columbia University Courtagen Life Sciences, Inc. CS-Keys, Inc. Dartmouth College Di.V.A.L Toscana srl diaDexus, Inc. DiagnoCure Inc. Diaxonhit S.A. EDP Biotech Corporation Epigenomics AG Eureka Genomics Corporation Eventus Diagnostics, Inc. Exact Sciences Corporation Exiqon A/S Exosomics Siena SpA Fina Biotech GenomicTree, Inc. Ghent University GlycoZym Health Discovery Corporation Human Metabolome Technologies, Inc. Ikonisys, Inc. Innovative Health Diagnostics IntegraGen SA InterGenetics Incorporated IV Diagnostics, Inc. Lab21 Limited Laboratorios Alpha San Ignacio Pharma S.L. LX Diagnostics MabCure Inc. Matrix-Bio, Inc. Mayo Clinic MDxHealth SA Metabiomics Corporation Metabolomic Technologies Inc. Metabolon, Inc. MetaStat, Inc. Milagen, Inc. Miraculins Inc. Mode Dx Ltd. Myriad Genetics, Inc. Nanosphere, Inc. Neogenix Oncology, Inc. NetScientific Plc Norda ASA Novel Bio-spectrum Technologies, Inc. Nuclea Biotechnologies Inc. Nuvera Biosciences, Inc. OncoVista Innovative Therapies, Inc. Origin Sciences Limited Orion Genomics LLC OTraces Inc. Oxford Cancer Biomarkers Oxford Gene Technology Limited Pacific Edge Limited Panacea Pharmaceuticals, Inc. PleX Diagnostics Prediction Sciences Protagen AG Rosetta Genomics, Ltd. Scienion AG Seegene, Inc. Shuwen Biotech Co. Ltd. Siamab Therapeutics, Inc. Sienna Cancer Diagnostics Ltd Skuldtech France Sysmex Corporation Tel Aviv University Texas A&M University The Johns Hopkins University TheraDiag SA Todos Medical Universite De Lyon University of Alabama at Birmingham University of Chicago University of Texas at Austin US Biomarkers, Inc. Vanderbilt University Vermillion, Inc. Viomics Inc. Vitatex Inc. VolitionRX Ltd. XEPTAGEN SpA
Manager - Marketing
Reportstack Market Research